Cargando…

Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status

BACKGROUND: Several indices have been developed to predict survival of brain metastases (BM) based on prognostic factors. However, such models were designed for general brain metastases from different kinds of cancers, and prognostic factors vary between cancers and histological subtypes. Recently,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hongwei, Wang, Weili, Jia, Haixia, Lian, Jianhong, Cao, Jianzhong, Zhang, Xiaqin, Song, Xing, Jia, Sufang, Li, Zhengran, Cao, Xing, Zhou, Wei, Han, Songye, Yang, Weihua, Xi, Yanfen, Lian, Shenming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582515/ https://www.ncbi.nlm.nih.gov/pubmed/28597503 http://dx.doi.org/10.1111/1759-7714.12460

Ejemplares similares

Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases
por: Li, Hongwei, et al.
Publicado: (2017)

Best Supportive Care Versus Whole-Brain Irradiation, Chemotherapy Alone, or WBRT Plus Chemotherapy in Patients With Brain Metastases From Small-Cell Lung Cancer: A Case-Controlled Analysis
por: Li, Hongwei, et al.
Publicado: (2021)

The Clinical Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Brain Metastases from Non–Small Cell Lung Cancer-Harboring EGFR Mutations
por: Li, Hongwei, et al.
Publicado: (2020)

Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤10 mm on thin-section computed tomography
por: Xiang, Wenjing, et al.
Publicado: (2014)

Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma
por: Cao, Yiyuan, et al.
Publicado: (2017)

Deep learning for predicting the human epidermal growth factor receptor 2 status of breast cancer liver metastases based on contrast-enhanced computed tomography: a development and validation study
por: Liu, Meng, et al.
Publicado: (2023)

Tumor suppressive role of miR-33a-5p in pancreatic ductal adenocarcinoma cells by directly targeting RAP2A
por: Lian, Yanfen, et al.
Publicado: (2021)

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
por: Zhao, Wei, et al.
Publicado: (2022)

Epidermal growth factor receptor in glioblastoma
por: Xu, Hongsheng, et al.
Publicado: (2017)

Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity
por: Li, Ming, et al.
Publicado: (2022)

The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator
por: Xu, Yanbo, et al.
Publicado: (2022)

A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma
por: Li, Hui, et al.
Publicado: (2017)

Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysis
por: Zhu, Yixiang, et al.
Publicado: (2023)

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
por: Feilchenfeldt, J, et al.
Publicado: (2015)

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
por: Feilchenfeldt, J, et al.
Publicado: (2015)

Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma
por: Wang, Jinn-Li, et al.
Publicado: (2018)

CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway
por: Feng, Sitong, et al.
Publicado: (2023)

Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma
por: Yang, Huayu, et al.
Publicado: (2022)

Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response
por: Sun, Wen-Wen, et al.
Publicado: (2017)

A multi-omics machine learning framework in predicting the recurrence and metastasis of patients with pancreatic adenocarcinoma
por: Li, Shenming, et al.
Publicado: (2022)

The role of autophagy in hepatocellular carcinoma: friend or foe
por: Liu, Lian, et al.
Publicado: (2017)

Intensity-modulated radiation therapy combined with concomitant temozolomide for brain metastases from lung adenocarcinoma
por: Li, Jinli, et al.
Publicado: (2018)

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases
por: Shi, Liang, et al.
Publicado: (2021)

The risk factors for bone metastases in patients with colorectal cancer
por: Li, An-An, et al.
Publicado: (2018)

Cutaneous metastases of prostatic adenocarcinoma
por: Patne, Shashikant C.U., et al.
Publicado: (2015)

Ovarian Adenocarcinoma With Leptomeningeal Metastases
por: Bayas, Angel, et al.
Publicado: (2022)

Ensemble Learning-Based Pulse Signal Recognition: Classification Model Development Study
por: Yan, Jianjun, et al.
Publicado: (2021)

Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells
por: Ni, Jie, et al.
Publicado: (2018)

Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
por: Lim, Malcolm, et al.
Publicado: (2022)

Incidence and Risk of Treatment-Related Mortality with Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in Cancer Patients: A Meta-Analysis of 21 Randomized Controlled Trials
por: Li, Xing, et al.
Publicado: (2013)

Dynamic enhanced CT: is there a difference between liver metastases of gastroenteropancreatic neuroendocrine tumor and adenocarcinoma
por: Cui, Yong, et al.
Publicado: (2017)

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer
por: Sun, Bochen, et al.
Publicado: (2022)

Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases
por: Kong, Ling-Ling, et al.
Publicado: (2017)

Genome-Wide Identification and Characterization of SPL Family Genes in Chenopodium quinoa
por: Zhao, Hongmei, et al.
Publicado: (2022)

Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases
por: Wu, Xi, et al.
Publicado: (2022)

Efficacy of afatinib for pulmonary adenocarcinoma with leptomeningeal metastases harboring an epidermal growth factor receptor complex mutation (exon 19del+K754E): A case report
por: Ma, Chunhua, et al.
Publicado: (2020)

An ectopic paraganglioma supplied by the subclavian artery in the right supraclavicular fossa
por: Wang, Yang, et al.
Publicado: (2019)

Machine Learning-Based Radiomics for Prediction of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma
por: Lu, Jiameng, et al.
Publicado: (2022)

Identification of Hub Genes to Regulate Breast Cancer Spinal Metastases by Bioinformatics Analyses
por: He, Yongxiong, et al.
Publicado: (2021)

Computed Tomography Morphological Classification of Lung Adenocarcinoma and Its Correlation with Epidermal Growth Factor Receptor Mutation Status: A Report of 1075 Cases
por: Li, Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_76ee13ue8nudb0ufc6tur15b3f